Next-Generation Formulations / Line Extensions
Enhanced bone graft substitutes for specific surgical applications
DevelopmentActive
Key Facts
Indication
Enhanced bone graft substitutes for specific surgical applications
Phase
Development
Status
Active
Company
About Graftys
Graftys is a commercial-stage company focused on synthetic bone graft substitutes, serving the orthopedic and dental markets. Its core technology platform involves highly biocompatible and osteoconductive calcium phosphate cements that are injectable and set in situ. The company has successfully brought products to market in Europe and other regions, positioning itself in the growing global bone graft substitute market. Its strategy involves both direct commercialization and partnerships to expand its geographic and clinical reach.
View full company profile